Previous studies have shown that treatment of DM1 fibroblasts and myotubes by erythromycin lactobionate could rescue aberrant splicing of MBNL 1 and 2 exon 5 and the splicing of other MBNL dependent transcripts in a dose dependent manner [16, 17]. Here, MBNL1 is linked to myotonic dystrophy type 1.